Cargando…

Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand

BACKGROUND: Lung cancer is the leading cause of cancer death in Aotearoa New Zealand, killing over 1,700 people each year. Despite the burden of lung cancer in Aotearoa New Zealand, the popular press has referred to it as the cancer type that no one talks about. Here, we investigate one factor that...

Descripción completa

Detalles Bibliográficos
Autores principales: Godward, Jess, Riordan, Benjamin C., Winter, Taylor, Ashton, John C., Hunter, John, Scarf, Damian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439896/
https://www.ncbi.nlm.nih.gov/pubmed/36059801
http://dx.doi.org/10.1155/2022/2183055
_version_ 1784782185110175744
author Godward, Jess
Riordan, Benjamin C.
Winter, Taylor
Ashton, John C.
Hunter, John
Scarf, Damian
author_facet Godward, Jess
Riordan, Benjamin C.
Winter, Taylor
Ashton, John C.
Hunter, John
Scarf, Damian
author_sort Godward, Jess
collection PubMed
description BACKGROUND: Lung cancer is the leading cause of cancer death in Aotearoa New Zealand, killing over 1,700 people each year. Despite the burden of lung cancer in Aotearoa New Zealand, the popular press has referred to it as the cancer type that no one talks about. Here, we investigate one factor that may contribute to this state of affairs: lung cancer stigma. METHODS: Participants were university students and members of the general public. University students were recruited via an online experiment participation system in 2021. Members of the public were recruited via social media. All participants completed the Cancer Stigma Scale (CSS) for one of five cancer types (lung, cervical, breast, skin, or bowel). The CSS is a 25-item scale with six subscales: awkwardness, avoidance, severity, policy opposition, personal responsibility, and financial discrimination. RESULTS: The mean age of participants was 24.3 (Standard Deviation = 10.4). Data from each subscale were submitted to an analysis of covariance (ANCOVA), with cancer type as a between-participant factor (5: lung, cervical, breast, skin, or bowel) and stigma as the dependent variable. Relative to most other cancer types, people were more likely to avoid someone with lung cancer, view interacting with someone with lung cancer as more awkward, and view people with lung cancer as being responsible for their condition. CONCLUSION: The Health Research Council of New Zealand recently funded the very first trial of lung cancer screening in Aotearoa New Zealand. The current study suggests that addressing stigma will be essential for the success of such programs, with stigma likely influencing those who engage in such trials.
format Online
Article
Text
id pubmed-9439896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94398962022-09-03 Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand Godward, Jess Riordan, Benjamin C. Winter, Taylor Ashton, John C. Hunter, John Scarf, Damian J Oncol Research Article BACKGROUND: Lung cancer is the leading cause of cancer death in Aotearoa New Zealand, killing over 1,700 people each year. Despite the burden of lung cancer in Aotearoa New Zealand, the popular press has referred to it as the cancer type that no one talks about. Here, we investigate one factor that may contribute to this state of affairs: lung cancer stigma. METHODS: Participants were university students and members of the general public. University students were recruited via an online experiment participation system in 2021. Members of the public were recruited via social media. All participants completed the Cancer Stigma Scale (CSS) for one of five cancer types (lung, cervical, breast, skin, or bowel). The CSS is a 25-item scale with six subscales: awkwardness, avoidance, severity, policy opposition, personal responsibility, and financial discrimination. RESULTS: The mean age of participants was 24.3 (Standard Deviation = 10.4). Data from each subscale were submitted to an analysis of covariance (ANCOVA), with cancer type as a between-participant factor (5: lung, cervical, breast, skin, or bowel) and stigma as the dependent variable. Relative to most other cancer types, people were more likely to avoid someone with lung cancer, view interacting with someone with lung cancer as more awkward, and view people with lung cancer as being responsible for their condition. CONCLUSION: The Health Research Council of New Zealand recently funded the very first trial of lung cancer screening in Aotearoa New Zealand. The current study suggests that addressing stigma will be essential for the success of such programs, with stigma likely influencing those who engage in such trials. Hindawi 2022-08-26 /pmc/articles/PMC9439896/ /pubmed/36059801 http://dx.doi.org/10.1155/2022/2183055 Text en Copyright © 2022 Jess Godward et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Godward, Jess
Riordan, Benjamin C.
Winter, Taylor
Ashton, John C.
Hunter, John
Scarf, Damian
Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand
title Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand
title_full Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand
title_fullStr Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand
title_full_unstemmed Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand
title_short Lung Cancer Attracts Greater Stigma than Other Cancer Types in Aotearoa New Zealand
title_sort lung cancer attracts greater stigma than other cancer types in aotearoa new zealand
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439896/
https://www.ncbi.nlm.nih.gov/pubmed/36059801
http://dx.doi.org/10.1155/2022/2183055
work_keys_str_mv AT godwardjess lungcancerattractsgreaterstigmathanothercancertypesinaotearoanewzealand
AT riordanbenjaminc lungcancerattractsgreaterstigmathanothercancertypesinaotearoanewzealand
AT wintertaylor lungcancerattractsgreaterstigmathanothercancertypesinaotearoanewzealand
AT ashtonjohnc lungcancerattractsgreaterstigmathanothercancertypesinaotearoanewzealand
AT hunterjohn lungcancerattractsgreaterstigmathanothercancertypesinaotearoanewzealand
AT scarfdamian lungcancerattractsgreaterstigmathanothercancertypesinaotearoanewzealand